Shanghai InnoStar Bio-tech Co (SHSE:688710) Scaled Net Operating Assets: 0.36 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688710 Shanghai InnoStar Bio-tech Co Ltd SHSE:688710
33 GF Score
Price ¥75.04
! 8 Warning Signs
View Full Analysis

What is Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets?

Shanghai InnoStar Bio-tech Co SHSE:688710 +8.28% 33 Scaled Net Operating Assets is 0.36 as of Mar. 2026. GuruFocus rates SHSE:688710 with a GF Score™ of 33/100. The stock has 8 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai InnoStar Bio-tech Co's operating assets for the quarter that ended in Mar. 2026 was ¥2,030.6 Mil. Shanghai InnoStar Bio-tech Co's operating liabilities for the quarter that ended in Mar. 2026 was ¥865.6 Mil. Shanghai InnoStar Bio-tech Co's Total Assets for the quarter that ended in Dec. 2025 was ¥3,253.4 Mil. Therefore, Shanghai InnoStar Bio-tech Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.36.

Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets Chart

Shanghai InnoStar Bio-tech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.48 0.24 0.28 0.46 0.37

Shanghai InnoStar Bio-tech Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.39 0.39 0.38 0.36

SHSE:688710 vs LLY, JNJ, ABBV: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - General subindustry, Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets falls into.


SHSE:688710
33GF Score
Shanghai InnoStar Bio-tech Co Ltd SHSE:688710
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai InnoStar Bio-tech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(1966.351-775.73)/3219.541
=0.37

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3253.43 - 1287.079
=1966.351

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=891.414 - 104.59 - 11.094
=775.73

Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(2030.588-865.571)/3253.43
=0.36

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3372.38 - 1341.792
=2030.588

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=996.27 - 118.059 - 12.64
=865.571

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.36 mean?
Shanghai InnoStar Bio-tech Co (SHSE:688710) has a Scaled Net Operating Assets of 0.36 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Shanghai InnoStar Bio-tech Co and its competitors.
Is Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets too high?
Shanghai InnoStar Bio-tech Co's current Scaled Net Operating Assets is 0.36. Overall, Shanghai InnoStar Bio-tech Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets compare to LLY and JNJ?
Shanghai InnoStar Bio-tech Co's Scaled Net Operating Assets of 0.36 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Shanghai InnoStar Bio-tech Co and its competitors. Shanghai InnoStar Bio-tech Co's current Scaled Net Operating Assets is 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai InnoStar Bio-tech Co stock overvalued right now?
Shanghai InnoStar Bio-tech Co (SHSE:688710) has a current Scaled Net Operating Assets of 0.36. The current Scaled Net Operating Assets is 0.36. Shanghai InnoStar Bio-tech Co's overall GF Score™ is 33/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Shanghai InnoStar Bio-tech Co (SHSE:688710), the current Scaled Net Operating Assets is 0.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai InnoStar Bio-tech Co Business Description

Address No. 199 Guo Shoujing Road, Room 106, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.
33GF Score

Get the complete analysis for SHSE:688710

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥75.04
Price